Peripheral artery disease: Update on etiology, pathophysiology, diagnosis and treatment

Med Clin (Barc). 2023 Oct 27;161(8):344-350. doi: 10.1016/j.medcli.2023.06.005. Epub 2023 Jul 28.
[Article in English, Spanish]

Abstract

Peripheral artery disease (PAD) is a condition related to atherosclerosis affecting >200 million people worldwide, and it increases cardiovascular morbidity (mainly from myocardial infarction and stroke) and mortality. Indeed, PAD patients are classified as patients at very high cardiovascular risk. The most common manifestation of PAD is intermittent claudication, which is associated with reduced mobility and leg pain. Nevertheless, asymptomatic PAD is the most frequent form of PAD worldwide; therefore, it remains underdiagnosed and undertreated. The major risk factors for PAD are smoking, diabetes mellitus, hyperlipidemia, hypertension, overweight/obesity, age, male sex, and black race. Hence, the first and most relevant approach in PAD treatment is lifestyle management, with measures such as smoking cessation, healthy diet, weight loss, and regular physical exercise. This should also be supported by an optimal pharmacological approach including lipid-lowering drugs, antihypertensive drugs, antidiabetic agents, and antithrombotics.

Keywords: Diagnosis; Diagnóstico; Enfermedad arterial periférica; Epidemiology; Epidemiología; Factores de riesgo; Peripheral artery disease; Risk factors; Tratamiento; Treatment.

Publication types

  • Review

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Atherosclerosis* / complications
  • Humans
  • Intermittent Claudication / drug therapy
  • Intermittent Claudication / etiology
  • Male
  • Peripheral Arterial Disease* / diagnosis
  • Peripheral Arterial Disease* / etiology
  • Peripheral Arterial Disease* / therapy
  • Risk Factors

Substances

  • Antihypertensive Agents